Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Jeffrey Adam Novack

General Counsel at CareDx, Inc. (CDNA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $453K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 6SEC CDNACareDx, Inc. Sell Plan 2,188106,575 held (−2%) $46.15 $101K +38.0%
Aug 6SEC CDNACareDx, Inc. Sell Plan 500106,075 held (−0%) $46.75 $23K +36.2%
May 6SEC CDNACareDx, Inc. Sell Plan 2,688113,924 held (−2%) $20.68 $56K +207.9%
Feb 4SEC CDNACareDx, Inc. Sell Plan 4,441125,364 held (−3%) $20.56 $91K +209.7%
Dec 5SEC CDNACareDx, Inc. Sell Plan 7,00798,211 held (−7%) $19.15 $134K +232.5%
Dec 5SEC CDNACareDx, Inc. Sell Plan 28697,925 held (−0%) $19.75 $6K +222.4%
Nov 10SEC CDNACareDx, Inc. Sell Plan 2,688105,218 held (−2%) $15.52 $42K +310.2%
  • Sell

    General Counsel Jeffrey Adam Novack sold $101K of CDNA at $46.15 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jeffrey Adam Novack sold $23K of CDNA at $46.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jeffrey Adam Novack sold $56K of CDNA at $20.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jeffrey Adam Novack sold $91K of CDNA at $20.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jeffrey Adam Novack sold $134K of CDNA at $19.15 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Jeffrey Adam Novack sold $6K of CDNA at $19.75 — pre-scheduled 10b5-1 plan sale.